pmc logo image
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors
Journal List > J Clin Pathol > v.44(6); Jun 1991

Formats:
J Clin Pathol. 1991 June; 44(6): 480–482.
PMCID: PMC496829
Copyright notice
Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy.
A B Okesina, D Donaldson, and P T Lascelles
Department of Chemical Pathology and Immunology, University of Ilorin, Nigeria.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
The effects of carbamazepine monotherapy were investigated in 20 female and 21 male epileptic patients to determine whether treatment would induce an increase in serum alkaline phosphatase (ALP) activity, a known effect of many anticonvulsant drugs. Serum total ALP activity was increased in nine out of the 41 patients (22%), serum bone ALP activity was increased in 10 (24%), and serum non-bone ALP activity was increased in three (7%). There was no significant difference when the mean of the patients' serum total ALP was compared with that of the controls. Twenty per cent of the patients with increased serum bone ALP had normal serum total ALP, indicating that increased serum bone isoenzyme activity may precede an increase in the total enzyme activity. This should be considered when interpreting results of increased total ALP in epileptic patients.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (524K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 480
480
icon of scanned page 481
481
icon of scanned page 482
482
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Richens A, Rowe DJ. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–76. [PubMed]
  • Siest G, Batt AM, Galteau MM, Weber M, Tridon P. Interférence des contraceptifs oraux et des anti-épileptiques sur les paramétres plasmatiques chez l'homme. Etude particulière des enzymes. Therapie. 1974 Nov–Dec;29(6):907–914. [PubMed]
  • Skillen AW, Pierides AM. Serum gamma glutamyl transferase and alkaline phosphatase activities in epileptics receiving anticonvulsant therapy. Clin Chim Acta. 1976 Oct 15;72(2):245–251. [PubMed]
  • O'Hare JA, Duggan B, O'Driscoll D, Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand. 1980 Nov;62(5):282–286. [PubMed]
  • Aldenhövel HG. The influence of long-term anticonvulsant therapy with diphenylhydantoin and carbamazepine on serum gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase. Eur Arch Psychiatry Neurol Sci. 1988;237(5):312–316. [PubMed]
  • Rosalki SB, Foo AY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984 Jul;30(7):1182–1186. [PubMed]
  • Behr W, Barnert J. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem. 1986 Oct;32(10):1960–1966. [PubMed]
  • Reynolds EH. Chronic antiepileptic toxicity: a review. Epilepsia. 1975 Jun;16(2):319–352. [PubMed]
  • Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970 Oct 10;4(5727):69–72. [PubMed]
  • Rapeport WG. Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy. Clin Neuropharmacol. 1985;8(2):141–149. [PubMed]
Articles from Journal of Clinical Pathology are provided here courtesy of
BMJ Group

PubMed articles by these authors